CDNA

CareDx, Inc.

SEC CIK 1217234
$26.18 +27.3% · 90 days
90-day buys
$0
0 open-market
90-day sells
$603.5K
5 open-market
Net insider flow
−$603.5K
Net selling
Filings shown
70
Most recent
Advertisement

At a glance

Over the last 90 days, insiders at CDNA have sold a net $603.5K of stock (0 open-market buys vs 5 sells).

Largest recent trade: Bell Michael Brian sold $1.61M of CDNA, trimming their stake 42%.

Most active filer: Goldberg Michael, with 24 transactions among the recent filings shown.

Insider transaction history

Form 4 filings for CDNA, newest first
View on SEC EDGAR ↗
CDNA
Sell Hanna John Walter JR · Director, President and CEO · Open-market sale · filed Jan 23, 2026 ΔOwn −3.1%

Hanna John Walter Jr sold $408K of CDNA, trimming their stake 3%.

−$408K
19,280 sh @ $21
CDNA
Sell Hanna John Walter JR · Director, President and CEO · Open-market sale · filed Jan 23, 2026

Hanna John Walter Jr sold $4.2K of CDNA.

−$4.2K
200 sh @ $21
CDNA
Sell Hanna John Walter JR · Director, President and CEO · Open-market sale · filed Jan 20, 2026 ΔOwn −1.6%

Hanna John Walter Jr sold $213.8K of CDNA, trimming their stake 2%.

−$213.8K
10,156 sh @ $21
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 5, 2025 ΔOwn −6.7%

Novack Jeffrey Adam sold $134.2K of CDNA, trimming their stake 7%.

−$134.2K
7,007 sh @ $19
Advertisement
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 5, 2025 ΔOwn −0.3%

Novack Jeffrey Adam sold $5.6K of CDNA.

−$5.6K
286 sh @ $20
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Nov 10, 2025 ΔOwn −2.5%

Novack Jeffrey Adam sold $41.7K of CDNA, trimming their stake 2%.

−$41.7K
2,688 sh @ $16
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Aug 7, 2025 ΔOwn −2.3%

Novack Jeffrey Adam sold $34.4K of CDNA, trimming their stake 2%.

−$34.4K
2,688 sh @ $13
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed May 7, 2025 ΔOwn −2.2%

Novack Jeffrey Adam sold $39.5K of CDNA, trimming their stake 2%.

−$39.5K
2,688 sh @ $15
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Apr 9, 2025 ΔOwn −0.7%

Novack Jeffrey Adam sold $16.4K of CDNA, trimming their stake 1%.

−$16.4K
924 sh @ $18
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Feb 5, 2025 ΔOwn −3.2%

Novack Jeffrey Adam sold $81.8K of CDNA, trimming their stake 3%.

−$81.8K
3,512 sh @ $23
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 6, 2024 ΔOwn −1.7%

Novack Jeffrey Adam sold $49.8K of CDNA, trimming their stake 2%.

−$49.8K
1,917 sh @ $26
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 3, 2024 ΔOwn −0.3%

Novack Jeffrey Adam sold $8.8K of CDNA.

−$8.8K
365 sh @ $24
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 3, 2024 ΔOwn −0.8%

Novack Jeffrey Adam sold $20.6K of CDNA, trimming their stake 1%.

−$20.6K
858 sh @ $24
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 3, 2024 ΔOwn −3.1%

Novack Jeffrey Adam sold $79.2K of CDNA, trimming their stake 3%.

−$79.2K
3,656 sh @ $22
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 3, 2024 ΔOwn −0.7%

Novack Jeffrey Adam sold $17.8K of CDNA, trimming their stake 1%.

−$17.8K
807 sh @ $22
CDNA
Sell Novack Jeffrey Adam · Secretary and General Counsel · Open-market sale · filed Dec 3, 2024 ΔOwn −0.9%

Novack Jeffrey Adam sold $23.6K of CDNA, trimming their stake 1%.

−$23.6K
1,071 sh @ $22
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Apr 13, 2022 ΔOwn −0.8%

Goldberg Michael sold $18K of CDNA, trimming their stake 1%.

−$18K
500 sh @ $36
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Mar 11, 2022 ΔOwn −0.8%

Goldberg Michael sold $16.7K of CDNA, trimming their stake 1%.

−$16.7K
500 sh @ $33
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Feb 10, 2022 ΔOwn −0.8%

Goldberg Michael sold $21.5K of CDNA, trimming their stake 1%.

−$21.5K
500 sh @ $43
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Jan 11, 2022 ΔOwn −0.8%

Goldberg Michael sold $21.5K of CDNA, trimming their stake 1%.

−$21.5K
500 sh @ $43
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Dec 13, 2021 ΔOwn −0.8%

Goldberg Michael sold $22.7K of CDNA, trimming their stake 1%.

−$22.7K
500 sh @ $45
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Nov 10, 2021 ΔOwn −0.8%

Goldberg Michael sold $23.8K of CDNA, trimming their stake 1%.

−$23.8K
500 sh @ $48
CDNA
Buy TORRES ARTHUR A · Director · Open-market purchase · filed Nov 9, 2021 ΔOwn +27%

Torres Arthur A, CDNA's Director, spent $28.6K of their own money on 600 shares at $48, growing their stake 27%.

+$28.6K
600 sh @ $48
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed Oct 12, 2021 ΔOwn −0.8%

Goldberg Michael sold $31.3K of CDNA, trimming their stake 1%.

−$31.3K
500 sh @ $63
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed May 12, 2021 ΔOwn −16%

Goldberg Michael sold $1.11M of CDNA, trimming their stake 16%.

−$1.11M
16,793 sh @ $66
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed May 12, 2021 ΔOwn −18%

Goldberg Michael sold $1.08M of CDNA, trimming their stake 18%.

−$1.08M
16,308 sh @ $66
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed May 12, 2021 ΔOwn −17%

Goldberg Michael sold $836.4K of CDNA, trimming their stake 17%.

−$836.4K
12,392 sh @ $67
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed May 12, 2021 ΔOwn −5.8%

Goldberg Michael sold $245.2K of CDNA, trimming their stake 6%.

−$245.2K
3,590 sh @ $68
CDNA
Sell Goldberg Michael · Director · Open-market sale · filed May 12, 2021 ΔOwn −8.2%

Goldberg Michael sold $403.5K of CDNA, trimming their stake 8%.

−$403.5K
6,042 sh @ $67
Advertisement

About CDNA insider activity

This page tracks every recent Form 4 filed for CareDx, Inc. with the U.S. Securities and Exchange Commission. Form 4 is the disclosure that company insiders — officers, directors, and holders of more than 10% of the stock — must file within two business days of buying or selling shares.

The summary above nets open-market purchases against open-market sales over the trailing 90 days. Open-market trades (codes P and S) tend to carry the most signal because they reflect a deliberate choice to put money in or take it out, as opposed to routine grants, option exercises, or tax-withholding events. Use the badges on each row to tell them apart, and always confirm details against the original filing before drawing conclusions.

Frequently asked questions

How often is CDNA insider data updated?

Continuously. We read from SEC EDGAR, so new Form 4 filings for CareDx, Inc. usually appear here within minutes of being accepted by the SEC.

What does "net insider flow" mean?

It is the total dollar value of open-market insider purchases minus open-market sales over the last 90 days. A positive number (green) means insiders bought more than they sold; a negative number (red) means the reverse.

Why do some rows show grants or option exercises instead of buys?

Insiders receive stock through compensation as well as buying it outright. Form 4 captures all of these. We label each transaction by its SEC code so you can focus on open-market activity if you prefer.

Is this investment advice?

No. InsiderSource presents public filing data for informational purposes only. Insider activity is one of many factors to consider and is never a recommendation to buy or sell.